BSE Live
Jan 22, 16:01Prev. Close
22.25
Open Price
22.00
Bid Price (Qty.)
21.25 (70)
Offer Price (Qty.)
22.25 (49)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Beryl Drugs (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.09 | 5.09 | 5.06 | 5.06 | 5.06 | |
| Total Share Capital | 5.09 | 5.09 | 5.06 | 5.06 | 5.06 | |
| Reserves and Surplus | 1.40 | 1.33 | 1.06 | 0.67 | 0.58 | |
| Total Reserves and Surplus | 1.40 | 1.33 | 1.06 | 0.67 | 0.58 | |
| Total Shareholders Funds | 6.50 | 6.42 | 6.12 | 5.73 | 5.64 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.19 | 0.15 | 0.13 | 0.08 | 0.06 | |
| Total Non-Current Liabilities | 0.21 | 0.15 | 0.13 | 0.09 | 0.07 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 1.68 | 1.54 | 0.89 | 0.89 | 1.03 | |
| Trade Payables | 2.22 | 1.35 | 1.44 | 1.70 | 1.25 | |
| Other Current Liabilities | 0.21 | 0.15 | 0.14 | 0.06 | 0.02 | |
| Short Term Provisions | 0.10 | 0.19 | 0.22 | 0.05 | 0.05 | |
| Total Current Liabilities | 4.21 | 3.22 | 2.69 | 2.69 | 2.35 | |
| Total Capital And Liabilities | 10.92 | 9.79 | 8.93 | 8.51 | 8.05 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 2.42 | 2.79 | 2.85 | 2.33 | 2.51 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.24 | 0.13 | 0.00 | 0.43 | 0.07 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 2.67 | 2.92 | 2.85 | 2.76 | 2.59 | |
| Non-Current Investments | 0.68 | 0.68 | 0.68 | 0.92 | 0.68 | |
| Deferred Tax Assets [Net] | 0.20 | 0.13 | 0.13 | 0.13 | 0.12 | |
| Long Term Loans And Advances | 0.95 | 1.13 | 1.26 | 0.72 | 0.71 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 4.50 | 4.85 | 4.92 | 4.53 | 4.09 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.06 | 0.56 | 0.00 | 0.00 | |
| Inventories | 1.50 | 1.41 | 0.84 | 1.31 | 1.83 | |
| Trade Receivables | 3.65 | 2.56 | 2.24 | 2.36 | 1.92 | |
| Cash And Cash Equivalents | 0.82 | 0.19 | 0.25 | 0.16 | 0.07 | |
| Short Term Loans And Advances | 0.44 | 0.72 | 0.13 | 0.15 | 0.14 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 6.42 | 4.94 | 4.02 | 3.98 | 3.96 | |
| Total Assets | 10.92 | 9.79 | 8.93 | 8.51 | 8.05 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1.04 | 0.03 | 0.01 | 0.96 | 0.96 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.97 | 0.97 | 0.61 | 0.49 | 0.21 | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | 0.06 | 0.56 | -- | -- |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y